At the 2025 World Vaccine Congress in Washington, DC, Avalere Health’s vaccine experts connected with leading industry and academic voices to discuss the evolving vaccine policy, access, value, and evidence landscape. Our team contributed to and led panels on methods and tools to support vaccine access as the landscape shifts.

Key Themes

1. Federal policy uncertainty. Across multiple sessions, particularly those on maintaining and increasing access, attendees voiced questions and concerns about how federal actions could affect the future of vaccines. While there are no clear answers, experts noted that many vaccine policy proposals are emerging at the state level (e.g., bills influencing school requirements and exemptions) and in the courts (e.g., challenges to actions by the Trump administration).
2. Near-term policy priorities, constrained by feasibility. During a pre-conference workshop on strategies to eliminate human papillomavirus (HPV), attendees were asked to rank their top ten priority activities to increase HPV vaccine uptake. Many prioritized strengthening school entry vaccination requirements but expressed concern that doing so would not be feasible in the current policy landscape. This theme carried through the rest of the conference in sessions on topics from product development to public health implementation.
3. Novel access strategies to support a growing adult vaccine pipeline. While several combination vaccines for adults are approaching launch, adequate access to and uptake of these products requires ensuring that providers are (1) appropriately reimbursed and can afford to stock and administer them, (2) guided by clear and simple recommendations, and (3) capable of overcoming vaccine hesitancy with evidence-based messaging.
4. The need to address vaccine hesitancy. Many experts discussed strategies to combat the trend of declining vaccine confidence in some communities. For example, some noted a preference for the word “immunization” over “vaccine,” which could inform provider strategies to increase uptake among at-risk patient populations. Others noted the effectiveness of storytelling.

How We Can Help

Avalere Health’s vaccine experts engaged in sessions on evidence generation, policy, and market access. Our team brought unique perspectives into discussions on the evolving role of the Advisory Committee on Immunization Practices, vaccine pricing and access considerations, policy strategies, and messaging for communications and education to help stakeholders across the vaccine ecosystem prepare for and respond to the changing landscape.

To learn how Avalere Health can help you prepare flexible evidence, policy, and access strategies in the face of uncertainty, connect with us.